4.7 Article

Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

Dannel Yeo et al.

Summary: This review summarizes the data on the utility of CTCs in PDAC and discusses the molecular profiling and culture methods of CTCs. CTCs have the potential to be used in screening, early diagnosis, prognostic assessment, and personalized management of PDAC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cell Biology

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications

Julian Goetze et al.

Summary: PDAC patients have a poor prognosis, with the tumor microenvironment's CAFs playing a crucial role, including myCAFs, iCAFs, and apCAFs. Research on CAFs helps in developing anti-stromal therapies, and cCAFs may serve as new liquid biopsy biomarkers.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Clinical Applications of Cancer-Associated Cells Present in the Blood of Cancer Patients

Cha-Mei Tang et al.

Summary: The ability to obtain tumor material from blood of cancer patients has significant advantages over the use of tumor tissue, with cancer-associated macrophage-like cells (CAMLs) being more useful than traditionally defined circulating tumor cells (CTCs) in some cases.

BIOMEDICINES (2022)

Review Cell Biology

Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance

Thais Pereira-Veiga et al.

Summary: The interaction between circulating tumor cells (CTCs) and blood cells plays a crucial role in metastatic progression and anti-metastatic therapies.

CELL REPORTS (2022)

Article Oncology

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

Christine Nitschke et al.

Summary: This study used a microfluidic-based approach to detect circulating tumor cells (CTCs) in patients with pancreatic ductal adenocarcinoma (PDAC), and assessed the expression of retinoic acid receptor responder 1 (RARRES1) on CTCs for the first time. The results showed that the detection rate of CTCs was higher during follow-up, and high CTC counts during follow-up in resected patients were associated with early tumor relapse. Combining CTC detection and RARRES1 expression could predict a worse prognosis in patients after curative operation during follow-up.

CANCERS (2022)

Article Medical Laboratory Technology

Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID

Rui P. L. Neves et al.

Summary: This study aimed to evaluate the effectiveness of multiple technologies for detecting circulating tumor cells, establishing a multi-center evaluation platform. Results showed significant differences in the performance of different technologies in detecting cell lines, which will help in establishing standards for future clinical applications.

CLINICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis

Desiree Loreth et al.

Summary: CTCs can serve as a disease surrogate for brain metastases in lung, melanoma, and breast cancer patients, with CD44 and CD74 expression as prognostic markers. Detection of CTCs using a size-based microfluidic approach and a semi-automated cell recognition system allows further characterization of tumor cells possibly derived from brain metastases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Liquid biopsy and minimal residual disease - latest advances and implications for cure

Klaus Pantel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Oncology

Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer

Katharina E. Effenberger et al.

CLINICAL CANCER RESEARCH (2018)

Article Oncology

Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions

Daniel L. Adams et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)

Review Oncology

Circulating tumor cell technologies

Meghaan M. Ferreira et al.

MOLECULAR ONCOLOGY (2016)

Article Multidisciplinary Sciences

Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients

Gary A. Clawson et al.

PLOS ONE (2015)

Article Oncology

Prognostic Role of Circulating Tumor Cells in Patients with Pancreatic Cancer: a Meta-analysis

Xue-Lei Ma et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Article Multidisciplinary Sciences

Circulating giant macrophages as a potential biomarker of solid tumors

Daniel L. Adams et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)